Daily spirometry in an acute exacerbation of adult cystic fibrosis patients.
Publication/Presentation Date
8-1-2018
Abstract
To help answer the question of length of intravenous antibiotics during an acute exacerbation of cystic fibrosis (CF), we had subjects to follow daily home spirometry while on intravenous antibiotics. CF patients, 18 and older, with an acute exacerbation requiring intravenous antibiotics had a daily FEV1. The average time to a 10% increase over their initial sick FEV1 was calculated, as well as the time to a new baseline. A total of 25 subjects completed the study. Ten of the 25 subjects did not have a sustainable 10% increase in FEV1. Of the 15 subjects with a sustainable 10% increase in FEV1, it took 5.2 days (±4.5) after day 1, while a new baseline was achieved on average at 6.6 days (±4.8) after day 1. Given the wide range of time to a 10% improvement and new baseline, it is recommended there should be flexibility in length of intravenous antibiotics in CF, not by a preset number.
Volume
15
Issue
3
First Page
258
Last Page
264
ISSN
1479-9731
Published In/Presented At
Stephen, M. J., Long, A., Bonsall, C., Hoag, J. B., Shah, S., Bisberg, D., Holsclaw, D., Varlotta, L., Fiel, S., Du, D., Zanni, R., & Hadjiliadis, D. (2018). Daily spirometry in an acute exacerbation of adult cystic fibrosis patients. Chronic respiratory disease, 15(3), 258–264. https://doi.org/10.1177/1479972317743756
Disciplines
Medicine and Health Sciences
PubMedID
29183160
Department(s)
Department of Medicine
Document Type
Article